Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Strategic Co-Development Partnership with Lantheus for Aus Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study January 2, 2025 Cygnus and Doré Copper Complete Merger January 2, 2025 CEOL Application and Amended 2024 Interim Results for ASX listing January 2, 2025
Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study January 2, 2025